Melanie M. Hagleitner

Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome)

Melanie M. Hagleitner, Arjan C. Lankester, P Maraschio et al. · Journal of Medical Genetics · 2007 · 215 citations

A First Step toward Personalized Medicine in Osteosarcoma: Pharmacogenetics as Predictive Marker of Outcome after Chemotherapy-Based Treatment

Melanie M. Hagleitner, Marieke J. H. Coenen, Hans Gelderblom et al. · Clinical Cancer Research · 2015 · 45 citations

Hematopoietic Stem Cell Transplantation Corrects the Immunologic Abnormalities Associated With Immunodeficiency–Centromeric Instability–Facial Dysmorphism Syndrome

Andrew R. Gennery, Mary Slatter, Robbert G. M. Bredius et al. · PEDIATRICS · 2007 · 44 citations

Immunodeficiencies, Immunology, Pathology +18

Survival Trends and Long-Term Toxicity in Pediatric Patients with Osteosarcoma

Melanie M. Hagleitner, Eveline S.J.M. de Bont, D. Maroeska W. M. te Loo · Sarcoma · 2012 · 39 citations · Full text

Age as prognostic factor in patients with osteosarcoma

Melanie M. Hagleitner, Peter M. Hoogerbrugge, Winette T.A. van der Graaf et al. · Bone · 2011 · 39 citations

Bone Disease, Longevity, Prognostic Factor +5